Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Longevity Vision Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 22
Average round size
info
The average size of a deal this fund participated in
$123M
Portfolio companies 15
Rounds per year 4.40
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.32
Exits 3
Key employees 2

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Therapeutics
Summary

The main office of represented VC is situated in the New York. The company was established in North America in United States.

The important activity for fund was in 2019. Deals in the range of 50 - 100 millions dollars are the general things for fund. When the investment is from Longevity Vision Fund the average startup value is 100-500 millions dollars. The fund is generally included in 2-6 deals every year.

We can highlight the next thriving fund investment areas, such as Medical, Clinical Trials. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight LyGenesis. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.

The usual cause for the fund is to invest in rounds with 8-9 partakers. Despite the Longevity Vision Fund, startups are often financed by Founders Fund, Data Collective DCVC, Bold Capital Partners. The meaningful sponsors for the fund in investment in the same round are Bold Capital Partners, Wanxiang Healthcare Investments, Verily.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Longevity Vision Fund:
Typical Co-investors
Longevity Vision Fund is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Longevity Vision Fund:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
2invest Beau Vallon, Mahé, Seychelles
Fondaco SGR Italy, Piemont, Turin
HDS Capital New York, New York, United States
Liepin Beijing, Beijing, China
Milk Capital -
Procter & Gamble Company Cincinnati, Ohio, United States
Weizhuo Touzi China, Guangdong, Shenzhen
WertInvest Austria, Vienna
Yilai Investment Management -
Zhongqi Touzi China, Ürümqi, Xinjiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Senda Biosciences

Biotechnology
Life Science
$123M16 Aug 2022 Cambridge, Massachusetts, United States

Tessera Therapeutics

Biopharma
Biotechnology
Therapeutics
$300M19 Apr 2022 Cambridge, Massachusetts, United States

Biolinq

Biotechnology
Health Care
Medical Device
$100M02 Nov 2021 San Diego, California, United States

Laronde

Biotechnology
Medical
Therapeutics
$440M30 Aug 2021 Cambridge, Massachusetts, United States

Exo

Health Care
Medical
Medical Device
$220M29 Jul 2021 Redwood City, California, United States

Senda Biosciences

Biotechnology
Life Science
$98M10 Jun 2021 Cambridge, Massachusetts, United States

Tessera Therapeutics

Biopharma
Biotechnology
Therapeutics
$230M12 Jan 2021 Cambridge, Massachusetts, United States

Valo Health

Biotechnology
Health Care
Medical
$190M11 Jan 2021 Boston, Massachusetts, United States

Eko

Artificial Intelligence
Health Care
Health Diagnostics
Machine Learning
Medical Device
mHealth
Software
$65M09 Nov 2020 Oakland, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Longevity Vision Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 22
Average round size 123M
Rounds per year 4.40
Peak activity year 2019
Lead investments 1
Follow on index 0.32
Exits 3
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Senda Biosciences

Biotechnology
Life Science
$123M16 Aug 2022 Cambridge, Massachusetts, United States

Tessera Therapeutics

Biopharma
Biotechnology
Therapeutics
$300M19 Apr 2022 Cambridge, Massachusetts, United States

Biolinq

Biotechnology
Health Care
Medical Device
$100M02 Nov 2021 San Diego, California, United States

Laronde

Biotechnology
Medical
Therapeutics
$440M30 Aug 2021 Cambridge, Massachusetts, United States

Exo

Health Care
Medical
Medical Device
$220M29 Jul 2021 Redwood City, California, United States

Senda Biosciences

Biotechnology
Life Science
$98M10 Jun 2021 Cambridge, Massachusetts, United States

Tessera Therapeutics

Biopharma
Biotechnology
Therapeutics
$230M12 Jan 2021 Cambridge, Massachusetts, United States

Valo Health

Biotechnology
Health Care
Medical
$190M11 Jan 2021 Boston, Massachusetts, United States

Eko

Artificial Intelligence
Health Care
Health Diagnostics
Machine Learning
Medical Device
mHealth
Software
$65M09 Nov 2020 Oakland, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: